# P&F Program

> **NIH NIH P30** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2020 · $96,239

## Abstract

This P&F program has been highly successful over the first five years of funding of this CDTR. Eight
investigators have been funded at $30,000/year for two years (total of $60,000 per investigator). In general,
year one of funding has come from the CDTR while year two has come from a combination of philanthropy or
shared expenditures with Vanderbilt's CTSA (see letter of support from Gordon Bernard, M.D., director of
Vanderbilt's CTSA). Four investigators have already received either a K award or a DP3 award and a fifth
awardee has secured a RO1 (two P&F recipients have pending K applications at the time of this writing – the
results of which will be updated on our website (https://labnodes.vanderbilt.edu/cdtr). Our R01 recipient
(Chandra Osborn, Ph.D.) who received a K award will lead a new core (Behavioral Intervention Technologies
and Services Core) that reflects both her research focus as well as research base demands. Translation core
investigators support both the design (structured statistical and measurement support pre-submission),
implementation and analysis of the P&F grants.
Vanderbilt CDTR proposes continuation of support for Pilot and Feasibility (P&F) funding for type II translation
research in diabetes through it's Administrative Core. These funds are used for: 1) new investigators; 2)
established investigators from other fields who bring their research expertise to diabetes; or 3) investigators in
diabetes research who wish to test a new idea. This funding mechanism provides support that will allow an
investigator the opportunity to develop the pilot data that will serve as the basis for obtaining independent
research support through conventional external, peer-reviewed granting mechanisms. Two P&F studies in any
one year (one new and one continuation) are funded and the funding is not intended for large undertakings by
established investigators for which it would be appropriate to submit separate research grant applications nor
to support or supplement ongoing research. Currently applicants must be a member of the VUMC or Meharry
faculty (Instructor or above) to submit a P&F proposal, and they must meet the NIH Eligibility Guidelines for
P&F support.

## Key facts

- **NIH application ID:** 10016278
- **Project number:** 5P30DK092986-11
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** TOM A ELASY
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $96,239
- **Award type:** 5
- **Project period:** 2011-09-01 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10016278

## Citation

> US National Institutes of Health, RePORTER application 10016278, P&F Program (5P30DK092986-11). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10016278. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*